30
Mar 2026
Ochsner Health welcomed Iberville Parish residents and families on Saturday, March 28 for the Iberville Parish Health Fair & Community Celebration, a no-cost community event focused on cancer awareness and prevention, and access to care close to home.
30
Mar 2026
Researchers at National Jewish Health and collaborating institutions have uncovered a critical mechanism driving persistent pulmonary fibrosis and identified a promising strategy to reverse it.
30
Mar 2026
Where previous research showed that PSMA therapy for prostate cancer can prolong the lives of patients who have exhausted all other treatment options, a new study now demonstrates that the therapy is also effective in an earlier stage of the disease.
30
Mar 2026
Why do stressful moments so often push people toward habits like drinking? A new study from Texas A&M University offers one of the clearest answers yet, identifying a direct connection inside the brain that links stress to addiction‑related behaviors.
30
Mar 2026
Researchers found that people with atrial fibrillation had lower MRI-based glymphatic activity and poorer cognitive performance than healthy controls, with the greatest impairment seen in non-paroxysmal AF. In patients who underwent catheter ablation, glymphatic activity improved after sinus rhythm was restored, suggesting a possible link between heart rhythm, brain waste clearance, and cognition.
30
Mar 2026
A randomized placebo-controlled trial found that fluvoxamine, a low-cost antidepressant, reduced fatigue and improved quality of life in adults with long COVID, offering one of the first evidence-based medication options for this persistent condition. In contrast, metformin did not provide meaningful benefit for established long COVID fatigue, highlighting fluvoxamine as the more promising treatment candidate in this study.
30
Mar 2026
Researchers led by the Fisabio Foundation found that dermcidin, a natural antimicrobial peptide present in sweat and respiratory tissues, can block influenza infection by binding to a highly conserved region of the viral hemagglutinin protein and preventing cell entry. The study also found that people who did not develop flu-like symptoms had markedly higher baseline dermcidin levels, suggesting the molecule may help reduce susceptibility to infection and could support the development of broader-spectrum antivirals.
30
Mar 2026
Researchers have developed a rapid direct-from-urine test that identifies which first-line antibiotic is likely to work for a urinary tract infection in an average of 5.85 hours, instead of the usual two to three days. In studies of 352 routine urine samples and 90 duplicate preservative-tested samples, the method showed high agreement with standard testing, suggesting it could speed treatment and support efforts to curb antimicrobial resistance.
30
Mar 2026
Breathing in common disinfectant chemicals known as quaternary ammonium compounds, or QACs, may be far more harmful than swallowing them, according to a mouse study led by researchers at the University of California, Davis.
30
Mar 2026
An irregular bedtime in midlife may signal an increased risk of cardiovascular disease. A new study from the University of Oulu suggests that large swings in when people go to bed could double the risk of serious cardiac events—particularly among those who get less than eight hours of sleep.
Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more
Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more
Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more
